Home Meetings Online CME/CE Clinical Resources Amazing Charts
Currently an exhibitor? Visit our Exhibitor Resource Center for up-to-date information.

Pri-Med East 2013

Location: Boston, MA
Date: September 19-22, 2013

Meeting Overview

Venue:
Boston Convention & Exhibition Center
Primary Audience:
Primary Care
Credits:
Refer to the Accreditation Tab

 

As a primary care clinician, you are at the center of patient care.

Online registration for this event is now closed so that we may prepare for the program. Onsite registration opens Thursday, September 19, 2013 at 7am.

Whether diagnosing and treating an acute illness or managing patients with complex medical needs, you ensure optimal patient outcomes. Managing multiple priorities—from daily patient care to office administration—makes it difficult to leave the office and recharge.

Pri-Med Conference & Exhibition offers low-cost continuing medical education in a flexible format. The CME conference schedule is designed to maximize your time out of the office, providing clinical updates on the disease states and patients you treat daily.

  • Women’s health
  • Pediatric and adolescent medicine
  • Cardiology for primary care clinicians
  • And many more topics for CME or CE credit

Earn up to 25.75 AMA PRA Category 1 Credits™.

For 2013, Harvard Medical School has developed a curriculum of relevant lectures so you’re primed to deliver the best patient care.

Register Today

Register for Pri-Med East by: Your price*
May 17 $30
July 12 $40
August 23 $55
September 15 $75
Onsite at Pri-Med East $100
Save Meeting to Your Calendar
Pri-Med East Mobile App--get the app!

Have any ideas on how Pri-Med can improve your continuing medical education experience? Email us; we’d love to hear what you think.

*Price represents online registration. Registration by phone is an additional $10.

Primary Care Updates tracks are sponsored by pmiCME. This is a limited-capacity ticketed event available on a first-come, first-served basis and by registration.

Primary Care Updates activities are produced independently of and are not affiliated with Harvard Medical School.

View the Pri-Med East
Full Conference Brochure

Pri-Med East Full Conference Brochure

 

View the Pri-Med East Daily

Pri-Med East Preview

 

Primary Care Updates*

September 19, 2013
A multi-track day of CME programs to supplement your education.

 

Current Clinical Issues in Primary Care

September 20–22, 2013
The core continuing medical education curriculum covering the latest topics in primary care medicine.

Harvard Medical School
 

Educational Symposia

Independent, non-Harvard Medical School accredited CME sessions to expand your learning.


Non-CME Opportunities at Pri-Med East
Be the first to know the latest innovations, technologies, and product research in the health care industry.

Exhibit Hall
Face-to-face conversations with industry professionals, helpful takeaways, and engaging floor activities.
Learn More »

Presentation Theaters
Live discussions led by prominent medical thought leaders. Get an in-depth look at the latest tools and treatment options.
Learn More »


Sessions & Syllabus

For your convenience, printer-friendly copies of the session slides will be available to view and download approximately 1 week prior to the event. Materials will not be provided on-site. Review session slides prior to attending the program and come equipped with questions for our faculty.

Primary Care Updates, Thursday, September 19, 2013 | Jump to:  Track 1  Track 2  Track 3 
  Primary Care Updates Track 1
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 1: Forest Research Institute, Inc., a subsidiary of Forest Laboratories, Inc., Lilly grant funding visit www.lillygrantoffice.com, Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com and Vivus.
7:00 AM-7:50 AM
Registration and Continental Breakfast
7:50 AM-8:00 AM
Opening Remarks
8:00 AM-9:15 AM
Clinical Challenges in Arthritis: Care Plans and Interventions That Achieve Results

Learning Objectives:

  1. Help your osteoarthritis patients manage their symptoms and improve their functioning by implementing proven, evidence-based clinical interventions
  2. Ensure early recognition and treatment of rheumatoid arthritis to prevent joint damage and disease progression
M. Susan Burke, MD, FACP (Read Bio), Clinical Assistant Professor, Thomas Jefferson University Medical School, Philadelphia, PA, Senior Advisor, Lankenau Medical Associates, Lankenau Medical Center, Wynnewood, PA
9:15 AM-9:30 AM
AM Break
9:30 AM-10:45 AM
Resistance is Futile: Functional Outcomes for Major Depressive Disorder

Learning Objectives:

  1. Choose initial evidence-based depression treatment that is specifically suited to the individual patient's need
  2. Monitor patients with depression over time in order to track treatment adherence, response, and side effects
  3. Make evidence-based treatment adjustments to address residual symptoms and side effects
Thomas L Schwartz, MD, Associate Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY
10:45 AM-12:00 PM
Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic

Learning Objectives:

  1. Identify and evaluate patients with obesity by using parameters such as body mass index, waist circumference, and risk factor assessment
  2. Engage patients in open dialogues, highlighting the importance of lifestyle modification including decreased energy intake and exercise as part of a healthy lifestyle
  3. Confidently utilize pharmacologic agents to reinforce lifestyle change for patients with obesity and obesity-related comorbid conditions
Robert Kushner, MD, Professor of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Donna H. Ryan, MD (Read Bio), Professor Emerita, Pennington Biomedical Research Center, Baton Rouge, LA
12:00 PM-12:45 PM
Lunch Break
12:45 PM-2:15 PM
Insulin Replacement Therapy for Type 2 Diabetes: Patient-Centered Management of Hyperglycemia in Primary Care

Learning Objectives:

  1. Discuss the multisystem consequences of T2DM and the rationale for appropriate screening, early diagnosis, and prompt treatment
  2. Establish individualized treatment goals for patients with T2DM according to disease duration, age, comorbidities, and ongoing evaluations of hemoglobin A1C, blood glucose profiles, and therapeutic responses
  3. Employ evidence-based frameworks and new treatment approaches to individualize basal and mealtime insulin therapies across diverse T2DM patient populations
  4. Integrate patient-specific clinical and psychosocial factors into comprehensive treatment plans that include lifestyle modifications and pharmacologic interventions for T2DM
  5. Educate patients with T2DM about the importance of treatment adherence and the risks of insulin-related hypoglycemia
Jeff Unger, MD, Assistant Professor of Family Medicine, Loma Linda University School of Medicine, Riverside, CA, Director, Metabolic Studies, Catalina Research Institute, Chino, CA
Mark W. Stolar, MD, Associate Professor of Clinical Medicine, Feinberg School of Medicine, Northwestern University Medical School, Chicago, IL
Derek LeRoith, MD, PhD, Professor of Medicine, Director of Research, Division of Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, New York, NY
2:15 PM-2:30 PM
PM Break
2:30 PM-4:00 PM
Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: Individualized Management in Primary Care

Learning Objectives:

  1. Describe pathophysiologic mechanisms in BPH-LUTS and relationships to comorbid conditions and therapeutic approaches
  2. Conduct comprehensive assessments of patients with suspected BPH and associated LUTS
  3. Evaluate the mechanisms of action and clinical profiles of a-blockers, 5-ARIs, and PDE5 inhibitors in the treatment of BPH-LUTS with and without ED
  4. Combine pharmacologic and nonpharmacologic interventions for BPH-LUTS based on symptom severity, common comorbidities, risk of disease progression, and patient goals
  5. Monitor treatment efficacy and adherence in patients with BPH-LUTS to guide therapeutic restructuring and optimize patient outcomes
Matt T Rosenberg, MD, Director and Founder, Mid-Michigan Health Centers, Jackson, MI, Chief, Department of Family Medicine, Foote Health System, Jackson, MI
David R. Staskin, MD, Associate Professor of Urology, Tufts University School of Medicine, Boston, MA, Director, Center for Male and Female Pelvic Health Steward, St. Elizabeth's Medical Center, Boston, MA
Steven A Kaplan, MD, E. Darracott Vaughan Jr. Professor of Urology, Chief, Institute for Bladder and Prostate Health, Weill Cornell Medical College, New York, NY, Director, Iris Cantor Men’s Health Center, New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY
  Primary Care Updates Track 2
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 2: Amarin Corporation plc, Bristol-Myers Squibb and AstraZeneca LP, Forest Laboratories, Inc., and Ironwood Pharmaceuticals., sanofi-aventis U.S. Inc. and Vivus.
7:00 AM-7:50 AM
Registration and Continental Breakfast
7:50 AM-8:00 AM
Opening Remarks
8:00 AM-9:30 AM
Incretin-Based Therapies for Type 2 Diabetes: Mechanism-Based Strategies to Achieve Patient-Centered Care

Learning Objectives:

  1. Discuss the multisystem causes and consequences of T2DM, including pathologic roles of the incretin pathways and rationale for early diagnosis
  2. Individualize treatment goals for patients with T2DM based on disease duration, age, relevant comorbidities, and ongoing evaluations of hemoglobin A1C levels and therapeutic responses
  3. Evaluate the mechanisms of action and clinical profiles of incretin-based therapies, including GLP-1 agonists and DPP-4 inhibitors
  4. Develop and tailor personalized multimodal treatment plans for T2DM that include lifestyle interventions and incretin-based therapies alone or in combination with other antihyperglycemic medications
  5. Educate diverse patient populations with T2DM about lifestyle modifications, benefits and risks of various antihyperglycemic medications, and the importance of treatment adherence
Lawrence Blonde, MD, FACP, FACE (Read Bio), Director of the Ochsner Diabetes Clinical Research Unit, Associate Internal Medicine Residency Program Direct, Ochsner Medical Center, New Orleans, LA
Jack L. Leahy, MD (Read Bio), Chief, Division of Endocrinology, Diabetes and Metabolism, University of Vermont, Burlington, VT
Javier Morales, MD (Read Bio),
9:30 AM-9:45 AM
AM Break
9:45 AM-11:00 AM
Tackling the Toughest Issues and Cases of Hypertriglyceridemia

Learning Objectives:

  1. Discuss the role of elevated triglyceride levels in the assessment and diagnosis of dyslipidemia, including cardiovascular risk factors
  2. Apply best practices in the attainment of TG levels, including the role of fasting and nonfasting states in accurate evaluation
  3. Evaluate the management of hypertriglyceridemia through greater adherence to evidence-based practices and accepted guidelines
  4. Select potential new and emerging therapeutic approaches to manage TG-based dyslipidemia, mixed dyslipidemia, and associated cardiovascular risk
Eliot A. Brinton, MD, FAHA, FNLA (Read Bio), President, American Board of Clinical Lipidology, Jacksonville, FL, President, Utah Lipid Center, Salt Lake City, UT, Director, Atherometabolic Research, Utah Foundation for Biomedical Research, Salt Lake City, UT
William C. Cromwell, MD, FAHA, FNLA, Chief, Lipoprotein and Metabolic Disorders Institute, Raleigh, NC, Adjunct Associate Professor, Hypertension and Vascular Disease Center, Wake Forest University School of Medicine, Winston Salem, NC
11:00 AM-12:15 PM
Digesting the Facts in IBS: From Early Diagnosis to Effective Treatment Options

Learning Objectives:

  1. Evaluate the necessity of diagnostic testing in individual patients prior to diagnosis of IBS
  2. Choose appropriate nonpharmacologic or pharmacologic therapies to aid patients with IBS
  3. Manage the symptoms of IBS over the long term through effective treatment strategies
Brian E. Lacy, MD, PhD (Read Bio), Professor of Medicine, Dartmouth Medical School, Lebanon, NH, Director of the GI Motility Laboratory, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Lawrence R. Schiller, MD, FACS (Read Bio), Professor of Internal Medicine, Texas A&M Health Science Center, Dallas Campus, Dallas, TX, Program Director, Gastroenterology Fellowship, Baylor University Medical Center, Dallas, TX
12:15 PM-1:00 PM
Lunch Break
1:00 PM-2:30 PM
Complementary Therapies to Improve Glucose Control in Type 2 Diabetes: Role of GLP-1 Receptor Agonists & Basal Insulin

Learning Objectives:

  1. Apply strategies to individualized therapy in the treatment of patients with type 2 diabetes
  2. Incorporate appropriate strategies for timely initiation, selection, titration, and self-management of basal insulin in patients with type 2 diabetes
  3. Describe the similarities and differences between individual GLP-1 receptor agonists
  4. Summarize the clinical rationale and evidence for combining GLP-1 receptor agonists with basal insulin so as to address various underlying pathophysiologic components of type 2 diabetes
Andrew Ahmann, MD, MS, Professor of Medicine, Director, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, OR
Robert J. Tanenberg, MD, FACP, Professor of Medicine, Division of Endocrinology, Medical Director, Inpatient Diabetes Program, Vidant Medical Center, East Carolina University, Greenville, NC, Medical Director, East Carolina University Diabetes and Obesity Institute, Greenville, NC, Medical Director, Inpatient Diabetes Program, Pitt County Memorial Hospital, Greenville, NC
2:30 PM-2:45 PM
PM Break
2:45 PM-4:00 PM
Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic

Learning Objectives:

  1. Identify and evaluate patients with obesity by using parameters such as body mass index, waist circumference, and risk factor assessment
  2. Engage patients in open dialogues, highlighting the importance of lifestyle modification including decreased energy intake and exercise as part of a healthy lifestyle
  3. Confidently utilize pharmacologic agents to reinforce lifestyle change for patients with obesity and obesity-related comorbid conditions
Timothy Church, MD, MPH, PhD (Read Bio), Professor and Director, Laboratory of Preventive Medicine, Pennington Biomedical Research Center, Baton Rouge, LA
Donna H. Ryan, MD (Read Bio), Professor Emerita, Pennington Biomedical Research Center, Baton Rouge, LA
  Primary Care Updates Track 3
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 3: AstraZeneca, Forest Laboratories, Novo Nordisk Inc., PamLab and Vivus.
7:00 AM-7:50 AM
Registration and Continental Breakfast
7:50 AM-8:00 AM
Opening Remarks
8:00 AM-9:15 AM
Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic

Learning Objectives:

  1. Identify and evaluate patients with obesity by using parameters such as body mass index, waist circumference, and risk factor assessment
  2. Engage patients in open dialogues, highlighting the importance of lifestyle modification including decreased energy intake and exercise as part of a healthy lifestyle
  3. Confidently utilize pharmacologic agents to reinforce lifestyle change for patients with obesity and obesity-related comorbid conditions
Robert Kushner, MD, Professor of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Donna H. Ryan, MD (Read Bio), Professor Emerita, Pennington Biomedical Research Center, Baton Rouge, LA
9:15 AM-9:30 AM
AM Break
9:30 AM-11:00 AM
Reducing Risk in the Acute Coronary Syndrome Patient: Insights for Primary Care Clinicians

Learning Objectives:

  1. Describe fundamental pharmacokinetics, pharmacodynamics, and pharmacogenetics of oral antiplatelet therapies
  2. Discuss efficacy and safety data with oral antiplatelet therapies from ACS outcomes trials
  3. Identify therapies to reduce risk and recognize goals to achieve in the management of patients who have experienced an acute coronary syndrome
Roger S. Blumenthal, MD, Professor of Medicine, John Hopkins University School of Medicine, Baltimore, MD
Gregg Stone, MD (Read Bio), Professor of Medicine, Columbia University, New York, NY
11:00 AM-12:30 PM
Case Work: Evaluating GLP-1 Receptor Agonists in Patient-Centered Care for Type 2 Diabetes

Learning Objectives:

  1. Evaluate and apply current evidence regarding GLP-1 RA efficacy relative to other agents and across diabetes progression
  2. Evaluate and apply current evidence regarding safety of GLP-1 RAs, including recent data on specific label precautions (eg, thyroid cancer, pancreatitis, renal failure) and cardiovascular disease
  3. Evaluate and apply current evidence regarding tolerability and treatment satisfaction with GLP-1 RAs
  4. Evaluate and apply current evidence regarding nonglycemic effects of GLP-1 RAs (eg, effects on weight, blood pressure, lipid levels)
Jack L. Leahy, MD (Read Bio), Professor of Medicine, Chief, Division of Endocrinology, Diabetes and Metabolism, The University of Vermont, Colchester, VT
Jay Shubrook, DO, FACOFP, FAAFP, Associate Professor of Family Medicine, Director of Clinical Research, Director of Diabetes Fellowship, The Diabetes Institute at Ohio University, Heritage College of Osteopathic Medicine, Athens, OH
Frank Lavernia, MD (Read Bio), Founder and Director, The North Broward Diabetes Center, North Broward Medical Center, Pompano Beach, FL
12:30 PM-1:15 PM
Lunch Break
1:15 PM-2:30 PM
Depression: When Medical and Psychiatric Factors Collide

Learning Objectives:

  1. Identify the relationship between depression and medical factors (inflammatory, endocrine, metabolic)
  2. Select optimal treatments for patients with depression and comorbid medical conditions
  3. Assess the potential utility of biomarkers in the diagnosis and treatment of depression
Andrew J Cutler, MD (Read Bio), Courtesy Assistant Professor, Department of Psychiatry, University of Florida, Gainesville, FL, CEO & Chief Medical Officer, Florida Clinical Research Center, LLC, Maitland, FL
2:30 PM-2:45 PM
PM Break
2:45 PM-4:00 PM
Clarifying the Confusion of COPD: Implementing Guidelines and Good Practice

Learning Objectives:

  1. Evaluate the benefits of current COPD therapy in improving symptoms and decreasing exacerbations
  2. Utilize current guidelines for the diagnosis of COPD, including the use of spirometry and management of symptoms
  3. Integrate recently approved agents to help prevent and treat COPD exacerbations
Jill Ann Ohar, MD, Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine, Center for Genomics and Personalized Medicine Research, Comprehensive Cancer Center, Center for Worker Health, Director for Respiratory Therapy, Wake Forest Baptist Health, Winston-Salem, NC
Frank C. Sciurba, MD, FCCP, Associate Professor of Medicine and Education, Director, Emphysema/COPD Research Center, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
Friday, September 20, 2013
7:45 AM-8:45 AM Keynote Address
7:45 AM-8:45 AM
Martin A. Samuels, MD (Read Bio)
9:30 AM-11:30 AM Current Clinical Issues in Primary Care
Session 1: Ask the Expert: Neurology, Rheumatology, Hepatology

9:30 AM-11:30 AM Panel Discussion
Martin Samuels, MD (Read Bio)
Sanjiv Chopra, MD, MACP (Read Bio)
Dwight Robinson, MD (Read Bio)
Session 2: Live, On-stage Orthopedic Demonstration I

9:30 AM-10:30 AM Hand Infection and Compartment Syndrome
Charles Day, MD (Read Bio)
10:30 AM-11:30 AM A Lot Riding on My Shoulders
Frank Domino, MD (Read Bio)
Session 3: Hematology (ARS)

9:30 AM-10:10 AM Anemia: What to Look For to Clinch the Diagnosis
Lisa Weissmann, MD (Read Bio)
10:10 AM-10:50 AM Anticoagulants: New Strategies for Treatment
David Kuter, MD (Read Bio)
10:50 AM-11:30 AM Challenging Cases in Hematology
Rachel Rosovsky, MD (Read Bio)
11:45 AM-1:15 PM Lunch Symposia
11:45 AM-1:15 PM
James R. Gavin III, MD, PhD (Read Bio), Clinical Professor of Medicine, Emory University School of Medicine, Atlanta, GA, CEO & Chief Medical Officer, Healing Our Village, Inc, Atlanta, GA
Frank Lavernia MD (Read Bio), Founder and Director, The North Broward Diabetes Center, North Broward Medical Center, Pompano Beach, FL
Davida F Kruger MSN, BC-ADM, APRN, Certified Nurse Practitioner, Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Health System, Detroit, MI, Division of Endocrinology, Diabetes and Bone Mineral Disorders, Detroit, MI
Commercial Support: The CME activity is supported by an educational grant from Novo Nordisk Inc.
11:45 AM-1:15 PM
1:30 PM-3:30 PM Current Clinical Issues in Primary Care
Session 4A: Ask the Expert: The Eyes and Ears Have It

1:30 PM-3:30 PM Panel Discussion
Laura Fine, MD
R. William Mason, MD (Read Bio)
Session 5A: Women’s Health I (ARS)

1:30 PM-2:10 PM Case Studies in Vaginitis
Martin Quan, MD (Read Bio)
2:10 PM-2:50 PM Breast Cancer Prevention in Primary Care

The Harvard Medical School designates the presentation, Breast Cancer Prevention in Primary Care, for 0.5 credits of risk management study

Karen Carlson, MD (Read Bio)
2:50 PM-3:30 PM Contraception Update 2013
Martin Quan, MD (Read Bio)
Session 6A: Nephrology and Oncology

1:30 PM-2:10 PM Chronic Kidney Disease
Robert Stanton, MD (Read Bio)
2:10 PM-2:50 PM Cancer: Progress One Patient at a Time
Lowell Schnipper, MD
2:50 PM-3:30 PM When Should a Patient with Kidney Disease be Referred to a Nephrologist
Robert Stanton, MD (Read Bio)
4:00 PM-6:00 PM Current Clinical Issues in Primary Care
Session 4B: Psychiatry, Neurology, and Beyond

4:00 PM-4:40 PM Complete Treatment of Clinical Depression: The What and How
John Sharp, MD (Read Bio)
4:40 PM-5:20 PM Recent Advances in Stroke
Galen Henderson, MD (Read Bio)
5:20 PM-6:00 PM Sleep On It
Session 5B: Medical Potpourri: Topics of Interest (ARS)

4:00 PM-4:40 PM A Doctor as A Patient : Observations on Quality and Safety

The Harvard Medical School designates the presentation, A Doctor As A Patient: Observations on Quality and Safety, for 0.5 credits of risk management study

James Foody, MD, FACP (Read Bio)
4:40 PM-5:20 PM Managing Patient Expectations in a Changing Health Care Environment
Daniel Dunham, MD, MPH, FACP (Read Bio)
5:20 PM-6:00 PM What Dr. Martin Luther King, Jr. Would Want Us To Know About Health Care Disparities
Augustus White, MD
Session 6B: Domestic Violence & Sexual Abuse

4:00 PM-5:00 PM Domestic Violence: Secrets and Solutions
Jane Sillman, MD (Read Bio)
5:00 PM-6:00 PM Primary Care for the Sexually Abused Woman
Ellen Long-Middleton, PhD, RN, FNP (Read Bio)
Saturday, September 21, 2013
6:15 AM-7:45 AM Symposia
6:15 AM-7:45 AM
6:15 AM-7:45 AM
Adam S Fleisher MD, MAS, Director of Imaging, Banner Alzheimer's Institute, Phoenix, AZ, Medical Director, Alzheimer's Disease Cooperative Study, Phoenix, AZ, Associate Professor, Department of Neurosciences, University of California, San Diego, CA
Lon Schneider MD, MS, Director, USC Alzheimer's Disease Research and Clinical Center, Los Angeles, CA, Director, Pharmacology Program, USC NIH Alzheimer's Disease Research Center, Los Angeles, CA, Professor of Gerontology, USC Davis School of Gerontology, Los Angeles, CA
Eric G. Tangalos MD, FACP, Professor of Medicine, Mayo Clinic, Rochester, MN
Commercial Support: The CME activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com
7:45 AM-8:45 AM Keynote Address
7:45 AM-8:45 AM
Randol Barker, MACP, MD (Read Bio)
9:30 AM-11:30 AM Current Clinical Issues in Primary Care
Session 7: Gastroenterology and Hepatology (ARS)

9:30 AM-10:10 AM Celiac Sprue: Protean Manifestations
Daniel Leffler, MD, MS (Read Bio)
10:10 AM-10:50 AM Adventures in Liverland
Sanjiv Chopra, MD, MACP (Read Bio)
10:50 AM-11:30 AM C. difficile Infection: Not Just A Hospital Problem Anymore
Daniel Leffler, MD, MS (Read Bio)
Session 8: Medical and Legal Issues at the End of Life

9:30 AM-10:30 AM End-of-Life Care: Listening to the Patient

The Harvard Medical School designates Session 8: Medical and Legal Issues at the End of Life, for 2.0 credits of risk management study

Ellen Long-Middleton, PhD, RN, FNP (Read Bio)
10:30 AM-11:30 AM Ethical and Legal Dilemmas at End of Life

The Harvard Medical School designates Session 8: End-of-Life Care Studies and 2.0 credits of risk management study

Panagiota Caralis, FACP, MD, JD (Read Bio)
Session 9: Ask the Pediatric and Adolescent Medicine Expert: Dermatology, Allergy, Ophthalmology

9:30 AM-11:30 AM Panel Discussion
Jennifer Huang, MD
Andrew Macginnitie, MD
Danielle Ledoux, MD
11:45 AM-1:15 PM Lunch Symposia
11:45 AM-1:15 PM
Adam S Fleisher MD, MAS, Director of Imaging, Banner Alzheimer's Institute, Phoenix, AZ, Medical Director, Alzheimer's Disease Cooperative Study, Phoenix, AZ, Associate Professor, Department of Neurosciences, University of California, San Diego, CA
Lon Schneider MD, MS, Director, USC Alzheimer's Disease Research and Clinical Center, Los Angeles, CA, Director, Pharmacology Program, USC NIH Alzheimer's Disease Research Center, Los Angeles, CA, Professor of Gerontology, USC Davis School of Gerontology, Los Angeles, CA
Eric G. Tangalos MD, FACP
Commercial Support: The CME activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com
11:45 AM-1:15 PM
1:30 PM-3:30 PM Current Clinical Issues in Primary Care
Session 10A: Live, On-stage Orthopedic Demonstration II

1:30 PM-2:30 PM Evaluation and Management of Low Back Pain
James Heffernan, MD (Read Bio)
2:30 PM-3:30 PM Knee Examination
Thomas Gill, IV, MD
Session 11A: Pediatric & Adolescent Medicine I

2:30 PM-3:30 PM ADHD Is Not Just for Kids: Recent Research and the Primary Care of ADHD
William Barbaresi, MD
5:00 PM-6:00 PM Vaccine Updates: Back to the Future
Richard Malley, MD (Read Bio)
Session 12A: Medical Potpourri II (ARS)

1:30 PM-2:10 PM Choosing Wisely: Tests and Treatment
Jane Sillman, MD (Read Bio)
2:10 PM-2:50 PM Vaccines for Adults: Not So Simple Anymore
Nicholas Fiebach, MD (Read Bio)
2:50 PM-3:30 PM New Drugs for the PCP: What You Need to Know
Gerald Smetana, MD (Read Bio)
4:00 PM-6:00 PM Current Clinical Issues in Primary Care
Session 10B: Women’s Health II

4:00 PM-4:40 PM Heart Disease in Women
Nandita Scott, MD (Read Bio)
4:40 PM-5:20 PM Prescribing in Pregnancy and Lactation
Margaret Fitzgerald, MD, FAAN, FNP (Read Bio)
5:20 PM-6:00 PM Heart Disease in Pregnancy
Katherine Economy, MD (Read Bio)
Session 11B: Pediatric & Adolescent Medicine II

1:30 PM-2:30 PM Hormones, Food, and Our Environment
Harvey Katz, MD (Read Bio)
4:00 PM-5:00 PM "The Celiac Iceberg": Is it changing shape, or is this just Global Warning
Thomas Walker, MD
Session 12B: Cardiology (ARS)

4:00 PM-4:40 PM Peripheral Vascular Disease: A Journey of 1,000 Steps
Gregory Piazza, MD (Read Bio)
4:40 PM-5:20 PM Resistant Hypertension
Jane Sillman, MD (Read Bio)
5:20 PM-6:00 PM Preoperative Cardiac Evaluation: Risk Factors and Novel Risk Reduction Strategies
Gerald Smetana, MD (Read Bio)
6:15 PM-7:45 PM Symposia
6:15 PM-7:45 PM
6:15 PM-7:45 PM
Adam S Fleisher MD, MAS, Director of Imaging, Banner Alzheimer's Institute, Phoenix, AZ, Medical Director, Alzheimer's Disease Cooperative Study, Phoenix, AZ, Associate Professor, Department of Neurosciences, University of California, San Diego, CA
Lon Schneider MD, MS, Director, USC Alzheimer's Disease Research and Clinical Center, Los Angeles, CA, Director, Pharmacology Program, USC NIH Alzheimer's Disease Research Center, Los Angeles, CA, Professor of Gerontology, USC Davis School of Gerontology, Los Angeles, CA
Eric G. Tangalos MD, FACP, Professor of Medicine, Mayo Clinic, Rochester, MN
Commercial Support: The CME activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com
Sunday, September 22, 2013
7:45 AM-8:45 AM Keynote Address
7:45 AM-8:45 AM
Story Musgrave, MD, MS (Read Bio)
9:30 AM-11:30 AM Current Clinical Issues in Primary Care
Session 13: Innovations in Practice Management

9:30 AM-10:10 AM Team-Based Care: What Works
Karen Carlson, MD (Read Bio)
Ellen Long-Middleton, PhD, RN, FNP (Read Bio)
10:10 AM-10:50 AM Transitional Care Management
John Goodson, MD, FACP (Read Bio)
10:50 AM-11:30 AM The Power of Group: Making Group Visits Work in Your Practice
Kathleen Ulman, PhD (Read Bio)
Stephanie Eisenstat, MD (Read Bio)
Session 14: Ask the Expert: Infectious Disease, Cardiology, Pulmonology

9:30 AM-11:30 AM Panel Discussion
Paul Sax, MD (Read Bio)
Christopher Fanta, MD (Read Bio)
Gregory Piazza, MD (Read Bio)
Session 15: Interactive Problem Solving in Pediatric and Adolescent Medicine (ARS)

9:30 AM-10:10 AM More Than Just the Snore: Common Sleep Disorders in Adolescents
Dennis Rosen, MD (Read Bio)
10:10 AM-10:50 AM Challenging Cases: What's the Diagnosis? Disorders of the Breast
Harvey Katz, MD (Read Bio)
10:50 AM-11:30 AM Common Medical Renal Disease in Children: What to Do With Proteinuria and Hypertension
Michael Somers, MD (Read Bio)
1:30 PM-3:30 PM Current Clinical Issues in Primary Care
Session 16: Optimizing Management of Chronic Conditions

1:30 PM-2:40 PM Opiates for Chronic Pain: Decision Making, Risk Management, and Monitoring

The Harvard Medical School designates the presentation, Opiates for Chronic Pain: Decision Making, Risk Management, and Monitoring, for 1.0 credit of Opioid Education and Pain Management Training and 1.25 credits of risk management study

Marc Cohen, MD
Julia Lindenberg, MD
2:40 PM-3:30 PM Chronic Fatigue
Michael Curry, MD (Read Bio)
Session 17: Pulmonology

1:30 PM-2:10 PM Chronic Obstructive Pulmonary Disease: Preventable and Treatable
Christopher Fanta, MD (Read Bio)
2:10 PM-2:50 PM Bronchiectasis: New Ideas About an Old Disease
Christopher Fanta, MD (Read Bio)
2:50 PM-3:30 PM Smoking Cessation
Nancy Rigotti, MD (Read Bio)

Additional Opportunities

 
Product Theater
11
AM
12
PM
11:35 AM-12:20 PM
Cholinergic Inhibition Across All Stages of Alzheimer’s Disease
Brought to you by: Novartis Pharmaceuticals

11:35 AM-12:20 PM
Helping Manage Stroke Risk in Patients with NVAF
Brought to you by: Bristol-Myers Squibb & Pfizer Inc.

11:35 AM-12:20 PM
Chronic Management of Obesity: The Role of a Unique, Once-daily Treatment
Brought to you by: VIVUS, Inc

11:35 AM-12:20 PM
A Case-Based Approach to Treating OAB: Including Landmark Study Results
Brought to you by: Pfizer Inc.

12
PM
1
PM
12:40 PM-1:25 PM
Inflammatory Back Pain Recognition and Diagnosis
Brought to you by: AbbVie

12:40 PM-1:25 PM
Improving Glycemic Control Through DPP-4 Inhibition: Treatment Considerations for Adult Patients with Type 2 Diabetes
Brought to you by: Boehringer Ingelheim & Eli Lilly

12:40 PM-1:25 PM
Medical Mystery: A Case of Unexplained Recurrent Abdominal Pain
Brought to you by: ViroPharma Incorporated

 
Product Theater
9
AM
9:00 AM-9:30 AM
VASCEPA® A Therapy for the Treatment of Severe Hypertriglyceridemia
Brought to you by: Amarin Pharma, Inc.

9:00 AM-9:30 AM
Emerging Trends in Alzheimer’s Disease Management: Namenda™ XR—a Treatment Option for Moderate to Severe Patients
Brought to you by: Forest Pharmaceuticals, Inc.

11
AM
12
PM
11:35 AM-12:20 PM
COPD Care: Insights on Treatment Options An Open Gallery Event
Brought to you by: Forest Pharmaceuticals, Inc.

11:35 AM-12:20 PM
Evaluating and Treating Patients with Overactive Bladder
Brought to you by: Astellas Pharma U.S., Inc.

11:35 AM-12:20 PM
A Novel Treatment Option for Chronic Weight Management
Brought to you by: Eisai, Inc.

11:35 AM-12:20 PM
Current Management Strategies in the Treatment of Acute Coronary Syndrome
Brought to you by: AstraZeneca

12
PM
1
PM
12:40 PM-1:25 PM
A Low-Volume Formulation for the Treatment of Hypogonadism
Brought to you by: AbbVie

12:40 PM-1:25 PM
Exposing Sodium Glucose Cotransporters (SGLTs): A Hidden Contributor To Persistent Hyperglycemia in Type 2 Diabetes
Brought to you by: Boehringer Ingelheim & Eli Lilly

12:40 PM-1:25 PM
Individualizing Treatment for Your Asthma and Exercise-Induced Bronchospasm Patients
Brought to you by: Teva Respiratory

 
Product Theater
9
AM
9:00 AM-9:30 AM
A New Treatment Approach for Type 2 Diabetes
Brought to you by: Janssen Pharmaceuticals, Inc.

9:00 AM-9:30 AM
Dupuytren’s Contracture in Adults With a Palpable Cord: Clinical Overview and Treatment Options
Brought to you by: Auxilium Pharmaceuticals, Inc.

11
AM
12
PM
11:35 AM-12:20 PM
Reduction of Ischemic Stroke Risk vs Warfarin in Non-valvular Atrial Fibrillation
Brought to you by: Boehringer Ingelheim Pharmaceuticals, Inc.

11:35 AM-12:20 PM
LIVALO: Emerging Clinical Considerations and Key Attributes
Brought to you by: Kowa Pharmaceuticals

11:35 AM-12:20 PM
A Clinical Review of LINZESS
Brought to you by: Forest Pharmaceuticals, Inc.

11:35 AM-12:20 PM
Helicobacter pylori: From Diagnosis to Management
Brought to you by: OAPI - Medical Device Division

12
PM
1
PM
12:40 PM-1:25 PM
A Different Approach to Alzheimer's Disease: Axona® as an Alternate Fuel for the Brain
Brought to you by: Accera, Inc.

12:40 PM-1:25 PM
Pneumococcal Disease in Adults 50+: A Prevention Option for Your Patients
Brought to you by: Pfizer Inc.

Accreditation

Harvard Medical School 50x61

Current Clinical Issues in Primary Care

Accreditation for Current Clinical Issues in Primary Care

The educational program, Current Clinical Issues in Primary Care, is developed by the Course Development Committee of Harvard Medical School. All decisions about the program content and faculty are made exclusively by the Course Development Committee. It is the mission of the Course Development Committee to develop, present, and promote an educational opportunity that is timely, relevant, free of commercial influence, and of the highest quality. To that end, we welcome your comments about how better to serve your needs.

Credits Type Accreditation Statement Designation Statement
19 AMA PRA Category 1 Credits™ The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Harvard Medical School designates this live educational activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
19 AAFP This activity has been reviewed and is acceptable for up to 19 Prescribed credits by the American Academy of Family Physicians.
Pri-Med Institute 93x91

Primary Care Updates

Track One, Track Two, and Track Three

This educational program is conceived and created in accordance with Accreditation Council for Continuing Medical Education (ACCME) Accreditation Criteria, the ACCME Standards for Commercial Support℠, and ACCME Policies. Pri-Med faculty hail from a variety of institutions and participate in content development, along with pmiCME’s Advisory Boards and its expert review partner, Tufts Health Care Institute. All final decisions about program content are the responsibility of pmiCME.

Credits Type Accreditation Statement Designation Statement
6.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.75 AAFP This live activity, Primary Care Updates, with a begin date of 9/19/2013, has been reviewed and is acceptable for up to 6.75 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.75 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.75 contact hours of continuing education (which includes 3.375 hours of pharmacology).

Keynote Speakers

Martin Samuels, MD (Read Bio)

Presenting on:

  • The Neurological Exam: A Lost Art
    Friday (September 20, 2013), 7:45 AM-8:45 AM

Randol Barker, MACP, MD (Read Bio)

Presenting on:

Story Musgrave, MD, MS (Read Bio)

Presenting on:

Exhibit Hall

Pri-Med Exhibit Hall

Hours
Friday, September 20 8:30am–2:30pm
Saturday, September 21 8:30am–2:30pm
Sunday, September 22 8:30am–2pm

The Pri-Med Exhibit Hall is your chance to learn about and compare over 175 of the health care industry’s latest products, treatments, and technologies in one place.


Spend your time in the Exhibit Hall talking to company representatives, evaluating new options, and making purchasing decisions for your practice—all things you do not have time for in your daily schedule. 

Attendee Badge Information

Please Note: As a Pri-Med registrant, you will receive a badge and an Attendance Scan Card, which will have bar codes programmed with your name, address, and professional discipline. You will scan your bar code at the appropriate stations to obtain CME credit or nursing contact hours.

Scanning your card at an exhibit booth or non-CME activity gives the sponsor permission to use your contact information for future correspondence.

Exhibit Floor Highlights

Presentation Theaters

Join us for an informative snack break, lunch, or dinner discussion about the latest clinical information as it relates to a specific disease state.

Lunchtime workshops in the Presentation Theaters will focus on ways to boost revenue by adding ancillary products and services to your practice. Come and learn from some of the leading experts in the industry.


Pri-Med East Mobile App--get the app!

Exhibitor List

Company Name Booth Number
AbbVie 939
Aegis Sciences Corporation 527
Altriance Health LLC 827
Amarin Pharma Inc. 623
Amazing Charts Lab 855
American College of Physicians 540
AspirinWorks by Corgenix 712
AstraZeneca 738
Auxilium Pharmaceuticals, Inc. 631
BICOM, Inc - Diaton 601
Bionix 617
Boehringer Ingelheim Pharmaceuticals, Inc. 723
Calmoseptine 710
Chromogenex 732
Concentra Primary Care 834
COPD Foundation 750
CryoProbe 512
Daiichi Sankyo, Inc. 500
Derm101.com 832
DoctorDirectory.com Inc. 1030
Eisai, Inc. 539
Federal Bureau of Prisons 602
Genova Diagnostics, Inc 926
HAE: Learn About It, Talk About It 830
Hawaiian Moon 706
Health Mirror 1028
Hemosure Inc. 825
HydraFacial MD® - Edge Systems 807
InfiniteAloe 701
Janssen Pharmaceuticals, Inc. 838
Koven Technology, Inc 734
Laclede Inc 607
Magic Massage Therapy 702
Massachusetts Department of Public Health 955
Medical Protective 933
MetTrimMD 1031
Minute Clinic 610
MPR 514
NEJM Journal Watch 654
Novartis Pharmaceuticals 517
Novo Nordisk Inc. 913
OAPI- Medical Device Division 511
Omron Healthcare 532
Personna Industrial 1055
Pfizer Inc. 905
Pri-Med Visitor Center 655
Ringadoc 1039
Scarf King 700
SLP Inc 516
Steward Health Care System 1023
Take Care Health Systems 805
Takeda Pharmaceuticals U.S.A., Inc. 946
Televox Software, Inc. 718
The Dannon Company 733
The Wall Street Journal 924
Thinklabs Inc. 554
Verathon Medical 1002
ViroPharma Incorporated 605
Vitamix 808
Company Name Booth Number
Accera, Inc. 909
AltaPoint Data Systems 751
Alzheimers Association 823
Amazing Charts 846
American Academy of Anti-Aging Medicine 803
American Express Open 800
Astellas Pharma U.S., Inc. 811
Atossa Genetics 903
Availity 749
Biofilm, Inc. 1051
Bio-Oil 656
Boston Scientific 900
Cell Science Systems/ ALCAT 503
CME Corner 1013
ConnectRx 746
Crown Healthcare Apparel Service 1054
CryoSurgery, Inc 550
Darco International 730
Dermalogix Partners Inc 603
Doximity 506
Elsevier Medical Books 518
Forest Pharmaceuticals, Inc. 547
GlaxoSmithKline 1004
Harvard Vanguard Medical Associates 956
Health Diagnostic Laboratory 1015
Hemocue America 1033
HOLOGIC, Inc. 548
Infinite Therapeutics 707
Institute for Healthcare Improvement 504
Jarrow Formulas, Inc. 1035
Lab USA, Inc. 635
Lippincott Williams & Wilkins 530
Maico Diagnostics 555
Mederi Therapeutics, Inc 922
Merck 929
Micro Direct, Inc. 801
Mission Pharmacal Co 505
NeilMed Pharmaceuticals Inc 604
New York Times 923
Novo Nordisk Inc. 817
Nutramax Laboratories, Inc. 522
Office Ally 935
Pamlab, LLC 525
Pfizer Inc. 531
Pri-Med Recharge Lounge 711
QIAGEN 1041
Sanofi Pasteur Inc. 1006
SKM Jewelers 703
Southcoast Hospitals Group 1034
Summit Doppler / Wallach Surgical Devices 611
Take Shape for Life 731
Tec Laboratories, Inc. 1032
Teva Respiratory 1019
The Gideons International 806
Thermo Fisher Scientific, Inc. 716
US Army Medical Recruiting 902
ViroPharma Incorporated 524
Vital Nutrients 1049
WynnPharm Inc. 538
Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

Boston Convention & Exhibition Center
415 Summer St
Boston, MA 02210-1709
(617) 954-2000

Official Travel Provider

onPeak: Official Housing Provider Pri-Med's official housing partner is onPeak. onPeak is the only company endorsed by the Pri-Med event team to provide Pri-Med official housing. Please be aware of this if you are contacted by any other company and thank you for supporting the show by booking your hotel and travel through the official Pri-Med housing partner.

Online reservations for are simple and fast.

Stay at an Event Hotel for the lowest rate available.

Company
Exhibitors
Support
Terms
Tel: (877) 477-4633